nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—systemic scleroderma—systemic lupus erythematosus	0.508	1	CtDrD
Lisinopril—ACE—systemic lupus erythematosus	0.258	1	CbGaD
Lisinopril—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0171	0.181	CbGbCtD
Lisinopril—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.013	0.137	CbGbCtD
Lisinopril—ABCB1—Betamethasone—systemic lupus erythematosus	0.0111	0.118	CbGbCtD
Lisinopril—ABCB1—Prednisolone—systemic lupus erythematosus	0.011	0.116	CbGbCtD
Lisinopril—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0104	0.11	CbGbCtD
Lisinopril—ABCB1—Prednisone—systemic lupus erythematosus	0.0104	0.11	CbGbCtD
Lisinopril—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00982	0.104	CbGbCtD
Lisinopril—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00647	0.0685	CbGbCtD
Lisinopril—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A4—systemic lupus erythematosus	0.00635	0.333	CbGpPWpGaD
Lisinopril—ABCB1—Methotrexate—systemic lupus erythematosus	0.0052	0.0551	CbGbCtD
Lisinopril—ACE—tunica intima—systemic lupus erythematosus	0.00475	0.164	CbGeAlD
Lisinopril—ACE—umbilical vein—systemic lupus erythematosus	0.0029	0.1	CbGeAlD
Lisinopril—ACE2—Metabolism of Angiotensinogen to Angiotensins—ACE—systemic lupus erythematosus	0.0024	0.126	CbGpPWpGaD
Lisinopril—ACE—urine—systemic lupus erythematosus	0.00234	0.0806	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—ACE—systemic lupus erythematosus	0.00229	0.12	CbGpPWpGaD
Lisinopril—ACE2—nephron tubule—systemic lupus erythematosus	0.00193	0.0664	CbGeAlD
Lisinopril—ACE2—kidney—systemic lupus erythematosus	0.00169	0.0583	CbGeAlD
Lisinopril—ACE2—cortex of kidney—systemic lupus erythematosus	0.00165	0.0568	CbGeAlD
Lisinopril—ACE—endothelium—systemic lupus erythematosus	0.00137	0.0474	CbGeAlD
Lisinopril—ACE—blood plasma—systemic lupus erythematosus	0.00122	0.0421	CbGeAlD
Lisinopril—ACE2—lung—systemic lupus erythematosus	0.0012	0.0413	CbGeAlD
Lisinopril—ACE2—nervous system—systemic lupus erythematosus	0.00111	0.0383	CbGeAlD
Lisinopril—ACE2—central nervous system—systemic lupus erythematosus	0.00107	0.0369	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—NOS3—systemic lupus erythematosus	0.00107	0.0559	CbGpPWpGaD
Lisinopril—SLC15A1—nephron tubule—systemic lupus erythematosus	0.000878	0.0303	CbGeAlD
Lisinopril—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.000855	0.0448	CbGpPWpGaD
Lisinopril—SLC15A1—kidney—systemic lupus erythematosus	0.000772	0.0266	CbGeAlD
Lisinopril—ACE2—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.000705	0.0369	CbGpPWpGaD
Lisinopril—ACE—connective tissue—systemic lupus erythematosus	0.00065	0.0224	CbGeAlD
Lisinopril—ACE2—Peptide hormone metabolism—ACE—systemic lupus erythematosus	0.000632	0.0331	CbGpPWpGaD
Lisinopril—ACE—nephron tubule—systemic lupus erythematosus	0.000629	0.0217	CbGeAlD
Lisinopril—ACE—kidney—systemic lupus erythematosus	0.000553	0.0191	CbGeAlD
Lisinopril—ACE—cortex of kidney—systemic lupus erythematosus	0.000539	0.0186	CbGeAlD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.000504	0.0264	CbGpPWpGaD
Lisinopril—ACE—ACE Inhibitor Pathway—NOS3—systemic lupus erythematosus	0.000476	0.0249	CbGpPWpGaD
Lisinopril—ACE—lymphoid tissue—systemic lupus erythematosus	0.000475	0.0164	CbGeAlD
Lisinopril—ACE—bone marrow—systemic lupus erythematosus	0.000433	0.0149	CbGeAlD
Lisinopril—ABCB1—blood plasma—systemic lupus erythematosus	0.00043	0.0148	CbGeAlD
Lisinopril—ACE—lung—systemic lupus erythematosus	0.000392	0.0135	CbGeAlD
Lisinopril—Fosinopril—ACE—systemic lupus erythematosus	0.000373	0.141	CrCbGaD
Lisinopril—ACE—nervous system—systemic lupus erythematosus	0.000363	0.0125	CbGeAlD
Lisinopril—ACE—central nervous system—systemic lupus erythematosus	0.000349	0.012	CbGeAlD
Lisinopril—ACE—ACE Inhibitor Pathway—TGFB1—systemic lupus erythematosus	0.000315	0.0165	CbGpPWpGaD
Lisinopril—Spirapril—ACE—systemic lupus erythematosus	0.0003	0.114	CrCbGaD
Lisinopril—Moexipril—ACE—systemic lupus erythematosus	0.000288	0.109	CrCbGaD
Lisinopril—Quinapril—ACE—systemic lupus erythematosus	0.000268	0.101	CrCbGaD
Lisinopril—Cilazapril—ACE—systemic lupus erythematosus	0.000268	0.101	CrCbGaD
Lisinopril—Ramipril—ACE—systemic lupus erythematosus	0.000259	0.098	CrCbGaD
Lisinopril—Trandolapril—ACE—systemic lupus erythematosus	0.000259	0.098	CrCbGaD
Lisinopril—ABCB1—Allograft Rejection—IL21—systemic lupus erythematosus	0.000242	0.0127	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000241	0.0126	CbGpPWpGaD
Lisinopril—Benazepril—ACE—systemic lupus erythematosus	0.000233	0.088	CrCbGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000225	0.0118	CbGpPWpGaD
Lisinopril—ABCB1—nephron tubule—systemic lupus erythematosus	0.000222	0.00764	CbGeAlD
Lisinopril—Enalapril—ACE—systemic lupus erythematosus	0.000197	0.0743	CrCbGaD
Lisinopril—ABCB1—kidney—systemic lupus erythematosus	0.000195	0.00671	CbGeAlD
Lisinopril—ABCB1—cortex of kidney—systemic lupus erythematosus	0.00019	0.00654	CbGeAlD
Lisinopril—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000167	0.00577	CbGeAlD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000155	0.00815	CbGpPWpGaD
Lisinopril—ABCB1—bone marrow—systemic lupus erythematosus	0.000152	0.00525	CbGeAlD
Lisinopril—Nateglinide—PPARG—systemic lupus erythematosus	0.000146	0.0552	CrCbGaD
Lisinopril—ABCB1—lung—systemic lupus erythematosus	0.000138	0.00476	CbGeAlD
Lisinopril—ABCB1—nervous system—systemic lupus erythematosus	0.000128	0.00441	CbGeAlD
Lisinopril—ABCB1—central nervous system—systemic lupus erythematosus	0.000123	0.00424	CbGeAlD
Lisinopril—ACE2—Metabolism of proteins—ACE—systemic lupus erythematosus	0.000119	0.00625	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000118	0.0062	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000114	0.00599	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000107	0.00563	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000106	0.00557	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000103	0.00542	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	8.93e-05	0.00468	CbGpPWpGaD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	8.9e-05	0.00467	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	8.27e-05	0.00433	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	8.22e-05	0.00431	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—F2—systemic lupus erythematosus	6.99e-05	0.00366	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	6.74e-05	0.00353	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	6.51e-05	0.00341	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CCL2—systemic lupus erythematosus	6.23e-05	0.00326	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	6.22e-05	0.00326	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	6.05e-05	0.00317	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	5.84e-05	0.00306	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	5.77e-05	0.00303	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	5.69e-05	0.00298	CbGpPWpGaD
Lisinopril—Nateglinide—ALB—systemic lupus erythematosus	5.5e-05	0.0208	CrCbGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	5.01e-05	0.00263	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	4.68e-05	0.00246	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	4.42e-05	0.00232	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	4.42e-05	0.00232	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	4.3e-05	0.00226	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	4.11e-05	0.00216	CbGpPWpGaD
Lisinopril—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.99e-05	0.000447	CcSEcCtD
Lisinopril—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	3.99e-05	0.000447	CcSEcCtD
Lisinopril—Nausea—Leflunomide—systemic lupus erythematosus	3.98e-05	0.000447	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	3.97e-05	0.000446	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	3.97e-05	0.000445	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	3.97e-05	0.00208	CbGpPWpGaD
Lisinopril—Fatigue—Hydrocortisone—systemic lupus erythematosus	3.96e-05	0.000445	CcSEcCtD
Lisinopril—Vision blurred—Prednisone—systemic lupus erythematosus	3.95e-05	0.000443	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	3.94e-05	0.00207	CbGpPWpGaD
Lisinopril—Urethral disorder—Methotrexate—systemic lupus erythematosus	3.94e-05	0.000442	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	3.94e-05	0.000442	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	3.93e-05	0.000441	CcSEcCtD
Lisinopril—Pain—Hydrocortisone—systemic lupus erythematosus	3.93e-05	0.000441	CcSEcCtD
Lisinopril—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	3.93e-05	0.000441	CcSEcCtD
Lisinopril—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	3.93e-05	0.000441	CcSEcCtD
Lisinopril—Oedema—Dexamethasone—systemic lupus erythematosus	3.93e-05	0.000441	CcSEcCtD
Lisinopril—Oedema—Betamethasone—systemic lupus erythematosus	3.93e-05	0.000441	CcSEcCtD
Lisinopril—Insomnia—Triamcinolone—systemic lupus erythematosus	3.91e-05	0.000439	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	3.91e-05	0.00205	CbGpPWpGaD
Lisinopril—Insomnia—Methylprednisolone—systemic lupus erythematosus	3.91e-05	0.000438	CcSEcCtD
Lisinopril—Infection—Betamethasone—systemic lupus erythematosus	3.9e-05	0.000438	CcSEcCtD
Lisinopril—Infection—Dexamethasone—systemic lupus erythematosus	3.9e-05	0.000438	CcSEcCtD
Lisinopril—Ill-defined disorder—Prednisone—systemic lupus erythematosus	3.89e-05	0.000436	CcSEcCtD
Lisinopril—Paraesthesia—Triamcinolone—systemic lupus erythematosus	3.89e-05	0.000436	CcSEcCtD
Lisinopril—Feeling abnormal—Prednisolone—systemic lupus erythematosus	3.88e-05	0.000435	CcSEcCtD
Lisinopril—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	3.88e-05	0.000435	CcSEcCtD
Lisinopril—Anaemia—Prednisone—systemic lupus erythematosus	3.87e-05	0.000434	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	3.87e-05	0.00203	CbGpPWpGaD
Lisinopril—Shock—Betamethasone—systemic lupus erythematosus	3.86e-05	0.000433	CcSEcCtD
Lisinopril—Shock—Dexamethasone—systemic lupus erythematosus	3.86e-05	0.000433	CcSEcCtD
Lisinopril—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.86e-05	0.000433	CcSEcCtD
Lisinopril—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	3.84e-05	0.000431	CcSEcCtD
Lisinopril—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	3.84e-05	0.000431	CcSEcCtD
Lisinopril—Tachycardia—Dexamethasone—systemic lupus erythematosus	3.83e-05	0.00043	CcSEcCtD
Lisinopril—Tachycardia—Betamethasone—systemic lupus erythematosus	3.83e-05	0.00043	CcSEcCtD
Lisinopril—Angioedema—Prednisone—systemic lupus erythematosus	3.83e-05	0.00043	CcSEcCtD
Lisinopril—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.81e-05	0.000427	CcSEcCtD
Lisinopril—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.81e-05	0.000427	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.8e-05	0.000427	CcSEcCtD
Lisinopril—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.8e-05	0.000426	CcSEcCtD
Lisinopril—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	3.8e-05	0.000426	CcSEcCtD
Lisinopril—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	3.8e-05	0.000426	CcSEcCtD
Lisinopril—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	3.79e-05	0.000425	CcSEcCtD
Lisinopril—Malaise—Prednisone—systemic lupus erythematosus	3.78e-05	0.000424	CcSEcCtD
Lisinopril—Vertigo—Prednisone—systemic lupus erythematosus	3.76e-05	0.000422	CcSEcCtD
Lisinopril—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.76e-05	0.000422	CcSEcCtD
Lisinopril—Syncope—Prednisone—systemic lupus erythematosus	3.76e-05	0.000422	CcSEcCtD
Lisinopril—Tinnitus—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000421	CcSEcCtD
Lisinopril—Anorexia—Dexamethasone—systemic lupus erythematosus	3.74e-05	0.00042	CcSEcCtD
Lisinopril—Anorexia—Betamethasone—systemic lupus erythematosus	3.74e-05	0.00042	CcSEcCtD
Lisinopril—Urticaria—Prednisolone—systemic lupus erythematosus	3.74e-05	0.000419	CcSEcCtD
Lisinopril—Fatigue—Triamcinolone—systemic lupus erythematosus	3.73e-05	0.000419	CcSEcCtD
Lisinopril—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.72e-05	0.000418	CcSEcCtD
Lisinopril—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.72e-05	0.000417	CcSEcCtD
Lisinopril—Asthenia—Cyclosporine—systemic lupus erythematosus	3.71e-05	0.000416	CcSEcCtD
Lisinopril—Pain—Triamcinolone—systemic lupus erythematosus	3.7e-05	0.000415	CcSEcCtD
Lisinopril—Loss of consciousness—Prednisone—systemic lupus erythematosus	3.68e-05	0.000413	CcSEcCtD
Lisinopril—Hypotension—Dexamethasone—systemic lupus erythematosus	3.67e-05	0.000412	CcSEcCtD
Lisinopril—Hypotension—Betamethasone—systemic lupus erythematosus	3.67e-05	0.000412	CcSEcCtD
Lisinopril—Pruritus—Cyclosporine—systemic lupus erythematosus	3.66e-05	0.00041	CcSEcCtD
Lisinopril—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.65e-05	0.00041	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—systemic lupus erythematosus	3.65e-05	0.000409	CcSEcCtD
Lisinopril—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.63e-05	0.000408	CcSEcCtD
Lisinopril—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.63e-05	0.000408	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	3.63e-05	0.000407	CcSEcCtD
Lisinopril—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.62e-05	0.000406	CcSEcCtD
Lisinopril—Chills—Methotrexate—systemic lupus erythematosus	3.61e-05	0.000405	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.58e-05	0.000401	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.58e-05	0.000401	CcSEcCtD
Lisinopril—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.57e-05	0.0004	CcSEcCtD
Lisinopril—Arthralgia—Prednisone—systemic lupus erythematosus	3.57e-05	0.0004	CcSEcCtD
Lisinopril—Myalgia—Prednisone—systemic lupus erythematosus	3.57e-05	0.0004	CcSEcCtD
Lisinopril—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.57e-05	0.0004	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	3.56e-05	0.00187	CbGpPWpGaD
Lisinopril—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.56e-05	0.000399	CcSEcCtD
Lisinopril—Anxiety—Prednisone—systemic lupus erythematosus	3.55e-05	0.000399	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—systemic lupus erythematosus	3.55e-05	0.000399	CcSEcCtD
Lisinopril—Insomnia—Dexamethasone—systemic lupus erythematosus	3.55e-05	0.000398	CcSEcCtD
Lisinopril—Insomnia—Betamethasone—systemic lupus erythematosus	3.55e-05	0.000398	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.54e-05	0.000397	CcSEcCtD
Lisinopril—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.54e-05	0.000397	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.53e-05	0.000396	CcSEcCtD
Lisinopril—Paraesthesia—Betamethasone—systemic lupus erythematosus	3.53e-05	0.000396	CcSEcCtD
Lisinopril—Paraesthesia—Dexamethasone—systemic lupus erythematosus	3.53e-05	0.000396	CcSEcCtD
Lisinopril—Discomfort—Prednisone—systemic lupus erythematosus	3.52e-05	0.000395	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—systemic lupus erythematosus	3.52e-05	0.000395	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000393	CcSEcCtD
Lisinopril—Erythema—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000393	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.47e-05	0.000389	CcSEcCtD
Lisinopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	3.46e-05	0.00181	CbGpPWpGaD
Lisinopril—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.46e-05	0.000388	CcSEcCtD
Lisinopril—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.46e-05	0.000388	CcSEcCtD
Lisinopril—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.45e-05	0.000387	CcSEcCtD
Lisinopril—Urticaria—Triamcinolone—systemic lupus erythematosus	3.44e-05	0.000386	CcSEcCtD
Lisinopril—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.43e-05	0.000385	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.43e-05	0.000385	CcSEcCtD
Lisinopril—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.42e-05	0.000384	CcSEcCtD
Lisinopril—Dizziness—Cyclosporine—systemic lupus erythematosus	3.42e-05	0.000384	CcSEcCtD
Lisinopril—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.42e-05	0.000384	CcSEcCtD
Lisinopril—Oedema—Prednisone—systemic lupus erythematosus	3.42e-05	0.000384	CcSEcCtD
Lisinopril—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.41e-05	0.000383	CcSEcCtD
Lisinopril—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.41e-05	0.000383	CcSEcCtD
Lisinopril—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.41e-05	0.000383	CcSEcCtD
Lisinopril—Infection—Prednisone—systemic lupus erythematosus	3.4e-05	0.000381	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.39e-05	0.00038	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.39e-05	0.00038	CcSEcCtD
Lisinopril—Back pain—Methotrexate—systemic lupus erythematosus	3.39e-05	0.00038	CcSEcCtD
Lisinopril—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.39e-05	0.00038	CcSEcCtD
Lisinopril—Fatigue—Betamethasone—systemic lupus erythematosus	3.39e-05	0.00038	CcSEcCtD
Lisinopril—Fatigue—Dexamethasone—systemic lupus erythematosus	3.39e-05	0.00038	CcSEcCtD
Lisinopril—Shock—Prednisone—systemic lupus erythematosus	3.36e-05	0.000377	CcSEcCtD
Lisinopril—Pain—Betamethasone—systemic lupus erythematosus	3.36e-05	0.000377	CcSEcCtD
Lisinopril—Pain—Dexamethasone—systemic lupus erythematosus	3.36e-05	0.000377	CcSEcCtD
Lisinopril—Tachycardia—Prednisone—systemic lupus erythematosus	3.34e-05	0.000374	CcSEcCtD
Lisinopril—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.34e-05	0.000374	CcSEcCtD
Lisinopril—Skin disorder—Prednisone—systemic lupus erythematosus	3.32e-05	0.000373	CcSEcCtD
Lisinopril—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.31e-05	0.000371	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—systemic lupus erythematosus	3.3e-05	0.00037	CcSEcCtD
Lisinopril—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.3e-05	0.00037	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	3.29e-05	0.00172	CbGpPWpGaD
Lisinopril—Vomiting—Cyclosporine—systemic lupus erythematosus	3.29e-05	0.000369	CcSEcCtD
Lisinopril—Rash—Cyclosporine—systemic lupus erythematosus	3.26e-05	0.000366	CcSEcCtD
Lisinopril—Anorexia—Prednisone—systemic lupus erythematosus	3.26e-05	0.000366	CcSEcCtD
Lisinopril—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.26e-05	0.000365	CcSEcCtD
Lisinopril—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.25e-05	0.000365	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	3.25e-05	0.0017	CbGpPWpGaD
Lisinopril—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.25e-05	0.000364	CcSEcCtD
Lisinopril—Headache—Cyclosporine—systemic lupus erythematosus	3.24e-05	0.000363	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—systemic lupus erythematosus	3.24e-05	0.000363	CcSEcCtD
Lisinopril—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.24e-05	0.000363	CcSEcCtD
Lisinopril—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.24e-05	0.000363	CcSEcCtD
Lisinopril—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.21e-05	0.00036	CcSEcCtD
Lisinopril—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.21e-05	0.00036	CcSEcCtD
Lisinopril—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.21e-05	0.00036	CcSEcCtD
Lisinopril—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.19e-05	0.000358	CcSEcCtD
Lisinopril—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.18e-05	0.000357	CcSEcCtD
Lisinopril—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.18e-05	0.000357	CcSEcCtD
Lisinopril—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.18e-05	0.000357	CcSEcCtD
Lisinopril—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.16e-05	0.000355	CcSEcCtD
Lisinopril—Malaise—Methotrexate—systemic lupus erythematosus	3.16e-05	0.000354	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—systemic lupus erythematosus	3.15e-05	0.000353	CcSEcCtD
Lisinopril—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.14e-05	0.000353	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—systemic lupus erythematosus	3.13e-05	0.000352	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—F2—systemic lupus erythematosus	3.12e-05	0.00164	CbGpPWpGaD
Lisinopril—Urticaria—Betamethasone—systemic lupus erythematosus	3.12e-05	0.00035	CcSEcCtD
Lisinopril—Urticaria—Dexamethasone—systemic lupus erythematosus	3.12e-05	0.00035	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.12e-05	0.00035	CcSEcCtD
Lisinopril—Dizziness—Prednisolone—systemic lupus erythematosus	3.11e-05	0.000349	CcSEcCtD
Lisinopril—Asthenia—Triamcinolone—systemic lupus erythematosus	3.1e-05	0.000348	CcSEcCtD
Lisinopril—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.1e-05	0.000348	CcSEcCtD
Lisinopril—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.1e-05	0.000348	CcSEcCtD
Lisinopril—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.1e-05	0.000348	CcSEcCtD
Lisinopril—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.1e-05	0.000348	CcSEcCtD
Lisinopril—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.1e-05	0.000348	CcSEcCtD
Lisinopril—Insomnia—Prednisone—systemic lupus erythematosus	3.09e-05	0.000347	CcSEcCtD
Lisinopril—Nausea—Cyclosporine—systemic lupus erythematosus	3.07e-05	0.000345	CcSEcCtD
Lisinopril—Paraesthesia—Prednisone—systemic lupus erythematosus	3.07e-05	0.000344	CcSEcCtD
Lisinopril—Pruritus—Triamcinolone—systemic lupus erythematosus	3.06e-05	0.000343	CcSEcCtD
Lisinopril—Cough—Methotrexate—systemic lupus erythematosus	3.06e-05	0.000343	CcSEcCtD
Lisinopril—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.05e-05	0.000343	CcSEcCtD
Lisinopril—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.04e-05	0.000341	CcSEcCtD
Lisinopril—Dyspepsia—Prednisone—systemic lupus erythematosus	3.01e-05	0.000338	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	3e-05	0.00157	CbGpPWpGaD
Lisinopril—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3e-05	0.000336	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—systemic lupus erythematosus	2.98e-05	0.000334	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—systemic lupus erythematosus	2.98e-05	0.000334	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—systemic lupus erythematosus	2.98e-05	0.000334	CcSEcCtD
Lisinopril—Decreased appetite—Prednisone—systemic lupus erythematosus	2.97e-05	0.000333	CcSEcCtD
Lisinopril—Rash—Prednisolone—systemic lupus erythematosus	2.97e-05	0.000333	CcSEcCtD
Lisinopril—Dermatitis—Prednisolone—systemic lupus erythematosus	2.96e-05	0.000333	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.96e-05	0.000332	CcSEcCtD
Lisinopril—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.95e-05	0.000331	CcSEcCtD
Lisinopril—Fatigue—Prednisone—systemic lupus erythematosus	2.95e-05	0.000331	CcSEcCtD
Lisinopril—Headache—Prednisolone—systemic lupus erythematosus	2.95e-05	0.000331	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—systemic lupus erythematosus	2.95e-05	0.00033	CcSEcCtD
Lisinopril—Constipation—Prednisone—systemic lupus erythematosus	2.92e-05	0.000328	CcSEcCtD
Lisinopril—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.92e-05	0.000328	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.91e-05	0.00153	CbGpPWpGaD
Lisinopril—Rash—Hydrocortisone—systemic lupus erythematosus	2.9e-05	0.000325	CcSEcCtD
Lisinopril—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.9e-05	0.000325	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—systemic lupus erythematosus	2.88e-05	0.000323	CcSEcCtD
Lisinopril—Headache—Hydrocortisone—systemic lupus erythematosus	2.88e-05	0.000323	CcSEcCtD
Lisinopril—Dizziness—Triamcinolone—systemic lupus erythematosus	2.86e-05	0.000321	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.86e-05	0.000321	CcSEcCtD
Lisinopril—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.86e-05	0.00032	CcSEcCtD
Lisinopril—Infection—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000319	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	2.83e-05	0.00148	CbGpPWpGaD
Lisinopril—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.82e-05	0.000316	CcSEcCtD
Lisinopril—Asthenia—Dexamethasone—systemic lupus erythematosus	2.82e-05	0.000316	CcSEcCtD
Lisinopril—Asthenia—Betamethasone—systemic lupus erythematosus	2.82e-05	0.000316	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.8e-05	0.000314	CcSEcCtD
Lisinopril—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.8e-05	0.000314	CcSEcCtD
Lisinopril—Nausea—Prednisolone—systemic lupus erythematosus	2.8e-05	0.000314	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CCL2—systemic lupus erythematosus	2.78e-05	0.00146	CbGpPWpGaD
Lisinopril—Pruritus—Dexamethasone—systemic lupus erythematosus	2.78e-05	0.000312	CcSEcCtD
Lisinopril—Pruritus—Betamethasone—systemic lupus erythematosus	2.78e-05	0.000312	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—systemic lupus erythematosus	2.78e-05	0.000311	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.76e-05	0.00031	CcSEcCtD
Lisinopril—Vomiting—Triamcinolone—systemic lupus erythematosus	2.75e-05	0.000309	CcSEcCtD
Lisinopril—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.75e-05	0.000308	CcSEcCtD
Lisinopril—Nausea—Hydrocortisone—systemic lupus erythematosus	2.73e-05	0.000306	CcSEcCtD
Lisinopril—Rash—Triamcinolone—systemic lupus erythematosus	2.73e-05	0.000306	CcSEcCtD
Lisinopril—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.73e-05	0.000306	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—systemic lupus erythematosus	2.72e-05	0.000306	CcSEcCtD
Lisinopril—Rash—Methylprednisolone—systemic lupus erythematosus	2.72e-05	0.000305	CcSEcCtD
Lisinopril—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.72e-05	0.000305	CcSEcCtD
Lisinopril—Urticaria—Prednisone—systemic lupus erythematosus	2.72e-05	0.000305	CcSEcCtD
Lisinopril—Headache—Triamcinolone—systemic lupus erythematosus	2.71e-05	0.000304	CcSEcCtD
Lisinopril—Headache—Methylprednisolone—systemic lupus erythematosus	2.71e-05	0.000303	CcSEcCtD
Lisinopril—Body temperature increased—Prednisone—systemic lupus erythematosus	2.7e-05	0.000303	CcSEcCtD
Lisinopril—Abdominal pain—Prednisone—systemic lupus erythematosus	2.7e-05	0.000303	CcSEcCtD
Lisinopril—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.69e-05	0.000301	CcSEcCtD
Lisinopril—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.69e-05	0.000301	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—systemic lupus erythematosus	2.67e-05	0.0003	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.6e-05	0.000292	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	2.6e-05	0.00136	CbGpPWpGaD
Lisinopril—Dizziness—Betamethasone—systemic lupus erythematosus	2.6e-05	0.000291	CcSEcCtD
Lisinopril—Dizziness—Dexamethasone—systemic lupus erythematosus	2.6e-05	0.000291	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—systemic lupus erythematosus	2.58e-05	0.00029	CcSEcCtD
Lisinopril—Nausea—Triamcinolone—systemic lupus erythematosus	2.57e-05	0.000288	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000288	CcSEcCtD
Lisinopril—Nausea—Methylprednisolone—systemic lupus erythematosus	2.56e-05	0.000288	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000286	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—systemic lupus erythematosus	2.54e-05	0.000285	CcSEcCtD
Lisinopril—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.52e-05	0.000283	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.52e-05	0.000282	CcSEcCtD
Lisinopril—Vomiting—Dexamethasone—systemic lupus erythematosus	2.5e-05	0.00028	CcSEcCtD
Lisinopril—Vomiting—Betamethasone—systemic lupus erythematosus	2.5e-05	0.00028	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.48e-05	0.000279	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	2.48e-05	0.0013	CbGpPWpGaD
Lisinopril—Rash—Dexamethasone—systemic lupus erythematosus	2.48e-05	0.000278	CcSEcCtD
Lisinopril—Rash—Betamethasone—systemic lupus erythematosus	2.48e-05	0.000278	CcSEcCtD
Lisinopril—Dermatitis—Betamethasone—systemic lupus erythematosus	2.47e-05	0.000277	CcSEcCtD
Lisinopril—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.47e-05	0.000277	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.47e-05	0.000277	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—systemic lupus erythematosus	2.46e-05	0.000276	CcSEcCtD
Lisinopril—Headache—Dexamethasone—systemic lupus erythematosus	2.46e-05	0.000276	CcSEcCtD
Lisinopril—Headache—Betamethasone—systemic lupus erythematosus	2.46e-05	0.000276	CcSEcCtD
Lisinopril—Asthenia—Prednisone—systemic lupus erythematosus	2.45e-05	0.000275	CcSEcCtD
Lisinopril—Pain—Methotrexate—systemic lupus erythematosus	2.44e-05	0.000274	CcSEcCtD
Lisinopril—Pruritus—Prednisone—systemic lupus erythematosus	2.42e-05	0.000271	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	2.4e-05	0.00126	CbGpPWpGaD
Lisinopril—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.36e-05	0.000264	CcSEcCtD
Lisinopril—Diarrhoea—Prednisone—systemic lupus erythematosus	2.34e-05	0.000262	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.34e-05	0.000262	CcSEcCtD
Lisinopril—Nausea—Dexamethasone—systemic lupus erythematosus	2.33e-05	0.000262	CcSEcCtD
Lisinopril—Nausea—Betamethasone—systemic lupus erythematosus	2.33e-05	0.000262	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	2.31e-05	0.00121	CbGpPWpGaD
Lisinopril—Urticaria—Methotrexate—systemic lupus erythematosus	2.27e-05	0.000255	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	2.27e-05	0.00119	CbGpPWpGaD
Lisinopril—Dizziness—Prednisone—systemic lupus erythematosus	2.26e-05	0.000254	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.26e-05	0.000253	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.26e-05	0.000253	CcSEcCtD
Lisinopril—Vomiting—Prednisone—systemic lupus erythematosus	2.17e-05	0.000244	CcSEcCtD
Lisinopril—Rash—Prednisone—systemic lupus erythematosus	2.16e-05	0.000242	CcSEcCtD
Lisinopril—Dermatitis—Prednisone—systemic lupus erythematosus	2.15e-05	0.000242	CcSEcCtD
Lisinopril—Headache—Prednisone—systemic lupus erythematosus	2.14e-05	0.00024	CcSEcCtD
Lisinopril—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.11e-05	0.000236	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—systemic lupus erythematosus	2.05e-05	0.00023	CcSEcCtD
Lisinopril—Nausea—Prednisone—systemic lupus erythematosus	2.03e-05	0.000228	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.03e-05	0.00106	CbGpPWpGaD
Lisinopril—Pruritus—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000227	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	1.96e-05	0.00103	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.96e-05	0.00103	CbGpPWpGaD
Lisinopril—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.96e-05	0.000219	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—systemic lupus erythematosus	1.89e-05	0.000212	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—systemic lupus erythematosus	1.82e-05	0.000204	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	1.8e-05	0.000945	CbGpPWpGaD
Lisinopril—Rash—Methotrexate—systemic lupus erythematosus	1.8e-05	0.000202	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—systemic lupus erythematosus	1.8e-05	0.000202	CcSEcCtD
Lisinopril—Headache—Methotrexate—systemic lupus erythematosus	1.79e-05	0.000201	CcSEcCtD
Lisinopril—Nausea—Methotrexate—systemic lupus erythematosus	1.7e-05	0.00019	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	1.68e-05	0.000883	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.65e-05	0.000866	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.23e-05	0.000645	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.17e-05	0.000611	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.08e-05	0.000564	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.02e-05	0.000537	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	9.84e-06	0.000516	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	9.7e-06	0.000508	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	8.9e-06	0.000466	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	8.31e-06	0.000436	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	8.22e-06	0.000431	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.59e-06	0.000293	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	4.61e-06	0.000242	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	2.91e-06	0.000153	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—systemic lupus erythematosus	2.62e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	2.5e-06	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	2.29e-06	0.00012	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.9e-06	9.98e-05	CbGpPWpGaD
